Search by Drug Name or NDC

NDC 59779-0586-25 Senna 8.6 mg/1 Details

Senna 8.6 mg/1

Senna is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by CVS Pharmacy. The primary component is SENNOSIDES.

MedlinePlus Drug Summary

Senna is used on a short-term basis to treat constipation. It also is used to empty the bowels before surgery and certain medical procedures. Senna is in a class of medications called stimulant laxatives. It works by increasing activity of the intestines to cause a bowel movement.

Related Packages: 59779-0586-25
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Senna

Product Information

NDC	59779-0586
Product ID	59779-586_1ad1b084-e6c7-45d4-b0fd-07cbb4c851e8
Associated GPIs	46200060200303
GCN Sequence Number	019964
GCN Sequence Number Description	sennosides TABLET 8.6 MG ORAL
HIC3	D6S
HIC3 Description	LAXATIVES AND CATHARTICS
GCN	00701
HICL Sequence Number	001289
HICL Sequence Number Description	SENNOSIDES
Brand/Generic	Generic
Proprietary Name	Senna
Proprietary Name Suffix	n/a
Non-Proprietary Name	Sennosides
Product Type	HUMAN OTC DRUG
Dosage Form	TABLET
Route	ORAL
Active Ingredient Strength	8.6
Active Ingredient Units	mg/1
Substance Name	SENNOSIDES
Labeler Name	CVS Pharmacy
Pharmaceutical Class	n/a
DEA Schedule	n/a
Marketing Category	OTC MONOGRAPH NOT FINAL
Application Number	part334
Listing Certified Through	n/a

Package

Package Images

NDC 59779-0586-25 (59779058625)

Pricing Information	N/A
NDC Package Code	59779-586-25
Billing NDC	59779058625
Package	250 TABLET in 1 BOTTLE, PLASTIC (59779-586-25)
Marketing Start Date	2015-12-31
NDC Exclude Flag	N

Standard Product Labeling (SPL)/Prescribing Information SPL c3ba17b9-e34a-496d-9bb9-cd5c19c79f92 Details

Active ingredient (in each tablet)

Sennosides 8.6 mg

Purpose

Laxative

Uses

relieves occasional constipation (irregularity)
generally produces a bowel movement within 6- 12 hours.

Warnings

Do not use

laxative products for longer than 1 week unless directed by a doctor

Ask a doctor before using if you have

stomach pain
nausea
vomiting
noticed a sudden change in bowel habits that continues over a period of 2 weeks.

Stop use and ask a doctor if

you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

take preferably at bedtime or as directed by a doctor

age	starting dosage	maximum dosage
adults and children 12 years of age and over	2 tablets once a day	4 tablets twice a day
children 6 to under 12 years	1 tablet once a day	2 tablets twice a day
children 2 to under 6 years	1/2 tablets once a day	1 tablet twice a day
children under 2 years	ask a doctor	ask a doctor

Other information

each tablet contains: calcium 25 mg
store at 25o C (77o F); excursions permitted between 15-30ºC (59-86ºF)

Inactive Ingredients

croscarmellose sodium, dibasic calcium phosphate dihydrate, hypromellose, liquid paraffin*, magnesium stearate, maltodextrin*, microcrystalline cellulose, mineral oil*, polyethylene glycol*, polyvinyl alcohol*, silicon dioxide*, stearic acid*, sodium lauryl sulfate*, talc

*contains one or more of these ingredients

Questions or comments?

Call 1-877-753-3935 Monday-Friday 9AM-5PM EST

Principal Display Panel

Compare to the active ingredient in Senokot®†

Senna

Sennosides 8.6 mg

Laxative

Standardized senna concentrate

Natural vegetable laxative ingredient

Tablets

†This product is not manufactured or distributed by Purdue Products L.P., distributor of Senokot®.

TAMPER EVIDENT: DO NOT USE IF PRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING

Distributed by: CVS Pharmacy, Inc.

One CVS Drive, Woonsocket, RI 02895

CVS.com

1-800-SHOP CVS

Product Label

CVS Senna Tablets

INGREDIENTS AND APPEARANCE

SENNA

sennosides tablet

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:59779-586
Route of Administration	ORAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX)	SENNOSIDES	8.6 mg

Ingredient Name	Strength
Inactive Ingredients
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP)
HYPROMELLOSES (UNII: 3NXW29V3WO)
MAGNESIUM STEARATE (UNII: 70097M6I30)
MALTODEXTRIN (UNII: 7CVR7L4A2D)
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
MINERAL OIL (UNII: T5L8T28FGP)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
STEARIC ACID (UNII: 4ELV7Z65AP)
TALC (UNII: 7SEV7J4R1U)
SODIUM LAURYL SULFATE (UNII: 368GB5141J)
POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)
POLYVINYL ALCOHOL, UNSPECIFIED (UNII: 532B59J990)

Product Characteristics
Color	brown	Score	no score
Shape	ROUND	Size	9mm
Flavor		Imprint Code	0813;AV;TCL080;S8
Contains

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:59779-586-50	50 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product	12/31/2015	12/31/2023
2	NDC:59779-586-25	250 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product	12/31/2015	12/31/2023

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC monograph not final	part334	12/31/2015	12/31/2023

Labeler - CVS Pharmacy (062312574)

Revised: 10/2021

Document Id: 1ad1b084-e6c7-45d4-b0fd-07cbb4c851e8

Set id: c3ba17b9-e34a-496d-9bb9-cd5c19c79f92

Version: 5

Effective Time: 20211014